Role of TRP channels and calcium signaling in cerebral arteries.
TRP 通道和钙信号在脑动脉中的作用。
基本信息
- 批准号:8127689
- 负责人:
- 金额:$ 2.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-15 至 2012-07-09
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolAgonistAmericanArteriesBlood PressureBlood VesselsBlood flowCalciumCalcium ChannelCalcium SignalingCaliberCalmodulinCardiovascular DiseasesCationsCell membraneCerebrumChemicalsCoronary ArteriosclerosisDataDevelopmentDiglyceridesDiseaseElectrophysiology (science)EndotheliumEventGoalsHypertensionImageInositolInvestigationIon ChannelKnowledgeLeadMeasurementMediatingMediator of activation proteinMembraneMentholMolecularMuscle CellsNeuronsOsmolar ConcentrationPathogenesisPathway interactionsPlayPotassiumProcessRNA InterferenceRegulationReportingResistanceRoleSarcoplasmic ReticulumSignal PathwaySignal TransductionSmall Interfering RNASmooth MuscleSmooth Muscle MyocytesSodiumSpeedStimulusStretchingStrokeSynapsesTechnologyTemperatureTestingTissuesVascular Smooth MuscleVasoconstrictor AgentsWorkblood pressure regulationcerebral arteryconstrictioncostextracellularhypertension treatmentinduced pluripotent stem cellinhibitor/antagonistmembernerve supplynovelpressurereceptorresearch studyresponsevasoconstrictionvoltage
项目摘要
DESCRIPTION (provided by applicant): Cardiovascular diseases (CVD), such as hypertension, stroke, and coronary artery disease currently afflict millions of Americans and at an annual cost greater than $400 billion dollars. The mechanisms responsible for the pathogenesis of hypertension are not well understood and current treatments focus on the reduction of blood pressure, or the sequelae associated with it, rather than the contributing factors that lead to the disease. Transient Receptor Potential (TRP) channels, which have recently been shown to have an important role in the vasculature, present an exciting target for the development of novel treatment paradigms. Our recent findings demonstrate that TRPM4 mediates smooth muscle cell depolarization and vasoconstriction in response to both intraluminal pressure and receptor-dependent agonists. Recent reports have identified TRPC3 in agonist dependent vasoconstriction pathways. In addition, TRPC6 has been suggested to play a role in pressure-induced vasoconstriction pathways. All together, these findings suggest that TRPM4 acts as a downstream mediator of TRPC3 and TRPC6. Using electrophysiology, calcium imaging, and isolated vessel work in combination with RNAi technology, the current proposal will test the following three hypotheses; that TRPC3 and TRPC6 activity elicits calcium release from intracellular stores, that the calcium release from stores induces TRPM4 activity, and ultimately, that the proposed mechanism modulate vasoconstriction through agonist- and pressure-mediated pathways. The proposed studies will significantly enhance our understanding of the channel's regulation in the vasculature and further our knowledge of the roles of other TRP channels in modulating smooth muscle excitability. Relevance: The development of new preemptive treatments for hypertension is dependent on our understanding of the basic intrinsic mechanisms that control blood pressure. The proposed study will provide a novel molecular mechanism, as well as exciting potential targets for the development of novel treatments.
描述(由申请人提供):心血管疾病(CVD),如高血压、中风和冠状动脉疾病,目前折磨着数百万美国人,每年花费超过4000亿美元。高血压的发病机制尚不清楚,目前的治疗侧重于降低血压或与其相关的后遗症,而不是导致疾病的因素。瞬态受体电位(Transient Receptor Potential, TRP)通道最近被证明在脉管系统中具有重要作用,为开发新的治疗模式提供了一个令人兴奋的目标。我们最近的研究结果表明,TRPM4介导平滑肌细胞去极化和血管收缩,以响应腔内压力和受体依赖性激动剂。最近的报道已经确定了TRPC3在激动剂依赖性血管收缩途径中。此外,TRPC6已被认为在压力诱导的血管收缩途径中发挥作用。综上所述,这些发现表明TRPM4作为TRPC3和TRPC6的下游介质。利用电生理学、钙成像和分离血管工作与RNAi技术相结合,目前的提案将测试以下三个假设;TRPC3和TRPC6的活性诱导细胞内钙的释放,钙的释放诱导TRPM4的活性,最终,该机制通过激动剂和压力介导的途径调节血管收缩。所提出的研究将显著增强我们对该通道在脉管系统中的调节作用的理解,并进一步加深我们对其他TRP通道在调节平滑肌兴奋性中的作用的认识。相关性:新的高血压预防治疗的发展依赖于我们对控制血压的基本内在机制的理解。该研究将提供一种新的分子机制,并为开发新的治疗方法提供令人兴奋的潜在靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Albert Louis Gonzales其他文献
Albert Louis Gonzales的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Albert Louis Gonzales', 18)}}的其他基金
Amyloid-β Disruption of Pericyte Control of Capillary Hemodynamics
淀粉样蛋白-β 破坏毛细血管血流动力学的周细胞控制
- 批准号:
10658264 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Brain Pericytes and the Progression of Alzheimer's Disease
大脑周细胞与阿尔茨海默病的进展
- 批准号:
10331688 - 财政年份:2021
- 资助金额:
$ 2.75万 - 项目类别:
Brain Pericytes and the Progression of Alzheimer's Disease
大脑周细胞与阿尔茨海默病的进展
- 批准号:
10332753 - 财政年份:2019
- 资助金额:
$ 2.75万 - 项目类别:
Role of TRP channels and calcium signaling in cerebral arteries.
TRP 通道和钙信号在脑动脉中的作用。
- 批准号:
7910472 - 财政年份:2008
- 资助金额:
$ 2.75万 - 项目类别:
Role of TRP channels and calcium signaling in cerebral arteries.
TRP 通道和钙信号在脑动脉中的作用。
- 批准号:
7677356 - 财政年份:2008
- 资助金额:
$ 2.75万 - 项目类别:
Role of TRP channels and calcium signaling in cerebral arteries.
TRP 通道和钙信号在脑动脉中的作用。
- 批准号:
7547487 - 财政年份:2008
- 资助金额:
$ 2.75万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)